Ads Top

Pfizer, Moderna vaccines wouldn’t have got nod had they done phase 3 trials in 2nd wave: Krishna Ella

Hyderabad-based Bharat Biotech, the manufacturer of COVID-19 Covaxin, said the efficacy of its vaccine would have been 85 per cent against the original strain of the virus—the one that was first detected in China.

from Lifestyle News:Entertainment News,Bollywood Latest News,Box Office Collection Report,Movie Reviews
Read The Rest:financialexpress...

No comments:

Powered by Blogger.